Impact Factor: 7.883
Submit Paper
Volume 10, Issue 12 (December 2024)

Comparative Study Of Quality Of Marketed Product Of Branded And Generic Ranax Tablet

Impact Factor
7.883
Call For Paper
Volume 12 Issue 07

July 2026

Download Paper Format
Copyright Form
Share on:

Author(s)

Dr.Kapil Malviya Dr. Sandhya Godi

Abstract

This Study Provides A Comparative Evaluation Of Branded And Generic Ranolazine Tablets, (Ranax) Specifically Focusing On Ranozex 500 Mg, Available In The Indian Market For Managing Chronic Angina Linked To Ischemic Heart Disease (IHD). Ranolazine, The Act


Keywords

Ranax Ranazoline Generic Branded

Paper ID

IJSARTV10I12102581

Publication Date

December 16, 2024

Research Area

NA

Submit Your Paper to IJSART

Join the global research community with IJSART. Submit your paper, share your work, and gain worldwide recognition!